We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

The company has previously reached settlement agreements with more than 20 other generics ... a big victory for Merck, given that Januvia remains its third best-selling product after cancer ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Disruptive analytics’s Substack by Magnus Ofstad. In this ...

Merck KGaA is a healthcare/pharma company that I have been covering and investing in for about 2 years at this point. Q2 2024 ...

Over more than 20 years in the pharma industry ... and to direct R&D efforts where they can best help patients. To achieve this objective, in 2017, Merck launched a first-of-its-kind initiative ...

These stocks near 52-week lows could be ready to rebound.

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

Nov. 13, 2024 /PRNewswire/ — TileDB, the database designed for scientific discovery, announced today it is now utilized by 50% of the top 20 global pharmaceutical ... George was employed by Merck & Co ...